Design and Clinical Evaluation of a School Meal With Deworming Properties
Primary Purpose
Helminthiasis, Tinea Capitis, Anemia
Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Ujiplus
Albendazole
uji
Sponsored by
About this trial
This is an interventional treatment trial for Helminthiasis
Eligibility Criteria
Inclusion Criteria:
- Consenting parents and guardians
Exclusion Criteria:
- children with known allergy to papaya fruit products
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Placebo Comparator
Arm Label
Papaya seed porridge
Albendazole and Plain porridge
Plain porridge
Arm Description
Arm receiving porridge fortified with dried papaya seeds (Ujiplus)
Arm receiving the approved albendazole treatment of 400mg once with plain porridge daily (without papaya seeds)
arm receiving 300ml plain porridge daily (without papaya seeds)
Outcomes
Primary Outcome Measures
parasite egg count
ova and cyst counts of various helminths in stool sample at end of intervention
Secondary Outcome Measures
Body Mass Index for age
Height, Weight and age were collected. BMI was calculated using WHO guidelines.
school attendance
school register used to gather information of attendance, enrollment and retention of students
haemoglobin levels
blood sample is taken for hemoglobin amounts at start and end of intervention
Number of children with tinea capitis
Number of children with tinea capitis (ringworms) 60 days after randomization
Full Information
NCT ID
NCT02725255
First Posted
February 28, 2016
Last Updated
September 3, 2016
Sponsor
Kenya Medical Research Institute
Collaborators
United States Agency for International Development (USAID), Bill and Melinda Gates Foundation
1. Study Identification
Unique Protocol Identification Number
NCT02725255
Brief Title
Design and Clinical Evaluation of a School Meal With Deworming Properties
Official Title
Design and Clinical Evaluation of a School Meal With Deworming Properties
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
May 2015 (undefined)
Primary Completion Date
November 2015 (Actual)
Study Completion Date
March 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kenya Medical Research Institute
Collaborators
United States Agency for International Development (USAID), Bill and Melinda Gates Foundation
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Intestinal parasites (IP) are among the world's neglected tropical diseases. Morbidity due to IPs is greatest in school-age children who typically have the highest burden of infection. In 2001, WHO passed a resolution for the use of large-scale mass drug administration (MDA) of antihelminthic drugs to deworm children in developing countries. Though initially effective, there is concern that MDA might not be sustainable over extended periods especially considering the large children populations and the high frequency of dosing. Further, the MDAs exert increasing drug pressure on parasite populations, a circumstance that is likely to favor parasite genotypes that can resist anthelmintic drugs. There is hence a need for alternatives that are not only affordable and sustainable but easier to implement in the long term with a minimal chance of development of resistance. The investigators propose to develop and test the feasibility of a corn porridge meal fortified with papaya fruit extracts that have been shown to have antihelminthic properties. The investigators intend to evaluate its efficacy when given through school feeding programs and compare the outcome with albendazole- the recommended MDA agent for deworming school children. The investigators will design and formulate the product and test it among children in three primary schools in Western Kenya.
Detailed Description
Background: Soil transmitted helminthes (STHs) are among the world's neglected tropical diseases. Morbidity due to STHs is greatest in school-age children who typically have the highest burden of infection. In 2001, WHO passed a resolution for the use of large-scale mass drug administration (MDA) to deworm vulnerable children. Though effective, there is concern that MDA might not be sustainable over extended periods. Additionally the current MDA strategy do not consider child malnutrition, a very common malady in resource limited countries. The investigators report a pilot evaluation of an innovation that bundles school feeding and deworming.
The investigators designed a maize (corn) flour fortified with grounded dried papaya (Carica papaya) seeds and used it to prepare porridge as per the usual school meal recipe. Children from three primary schools from Nandi County in Kenya were randomized into three arms: One school received 300 ml papaya fortified porridge daily (test school), a second school received similar serving of plain porridge without the pawpaw ingredient (placebo) and a third school received the placebo porridge and the conventional MDA approach of one time 400mg dosage of albendazole. Prior to the randomization, an initial baseline stool microscopy analysis was done to determine presence and intensity of intestinal worms. Core indicators of nutrition-height, weight and hemoglobin counts-were also assessed. The children were monitored daily for two months and final stool sample analysis and clinical monitoring done at the end of the study. Baseline and follow-up data were analyzed and compared through SAS version 9.1 statistical package.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Helminthiasis, Tinea Capitis, Anemia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
326 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Papaya seed porridge
Arm Type
Experimental
Arm Description
Arm receiving porridge fortified with dried papaya seeds (Ujiplus)
Arm Title
Albendazole and Plain porridge
Arm Type
Active Comparator
Arm Description
Arm receiving the approved albendazole treatment of 400mg once with plain porridge daily (without papaya seeds)
Arm Title
Plain porridge
Arm Type
Placebo Comparator
Arm Description
arm receiving 300ml plain porridge daily (without papaya seeds)
Intervention Type
Dietary Supplement
Intervention Name(s)
Ujiplus
Intervention Description
Maize flour fortified with micronutrients and dried ground papaya (Carica papaya) seeds. The flour was used to prepare porridge and each child given a serving of 300 ml every school day for 60 days.
Intervention Type
Drug
Intervention Name(s)
Albendazole
Other Intervention Name(s)
Albenza
Intervention Description
400mg of albendazole given to each child once at the beginning of the study and maize flour porridge fortified only with micronutrients cooked and served to each child, 300ml per day for 60 days.
Intervention Type
Dietary Supplement
Intervention Name(s)
uji
Intervention Description
maize flour porridge fortified only with micronutrients, cooked and served to each child 300ml per day for 60 days.
Primary Outcome Measure Information:
Title
parasite egg count
Description
ova and cyst counts of various helminths in stool sample at end of intervention
Time Frame
60 days after randomization
Secondary Outcome Measure Information:
Title
Body Mass Index for age
Description
Height, Weight and age were collected. BMI was calculated using WHO guidelines.
Time Frame
60 days after intervention
Title
school attendance
Description
school register used to gather information of attendance, enrollment and retention of students
Time Frame
60 days after randomization
Title
haemoglobin levels
Description
blood sample is taken for hemoglobin amounts at start and end of intervention
Time Frame
baseline and after 60 days
Title
Number of children with tinea capitis
Description
Number of children with tinea capitis (ringworms) 60 days after randomization
Time Frame
60 days after randomization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Consenting parents and guardians
Exclusion Criteria:
children with known allergy to papaya fruit products
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elijah M Songok, PhD
Organizational Affiliation
Kenya Medical Research Institute
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
17472487
Citation
Okeniyi JA, Ogunlesi TA, Oyelami OA, Adeyemi LA. Effectiveness of dried Carica papaya seeds against human intestinal parasitosis: a pilot study. J Med Food. 2007 Mar;10(1):194-6. doi: 10.1089/jmf.2005.065.
Results Reference
background
PubMed Identifier
11393524
Citation
Kermanshai R, McCarry BE, Rosenfeld J, Summers PS, Weretilnyk EA, Sorger GJ. Benzyl isothiocyanate is the chief or sole anthelmintic in papaya seed extracts. Phytochemistry. 2001 Jun;57(3):427-35. doi: 10.1016/s0031-9422(01)00077-2.
Results Reference
background
Citation
Ash LR, Orihel TC, Savioli L. Bench aids for the diagnosis of intestinal parasites. Geneva. World Health Organization, 1994
Results Reference
background
PubMed Identifier
23202594
Citation
Sapaat A, Satrija F, Mahsol HH, Ahmad AH. Anthelmintic activity of papaya seeds on Hymenolepis diminuta infections in rats. Trop Biomed. 2012 Dec;29(4):508-12.
Results Reference
background
PubMed Identifier
30526582
Citation
Kugo M, Keter L, Maiyo A, Kinyua J, Ndemwa P, Maina G, Otieno P, Songok EM. Fortification of Carica papaya fruit seeds to school meal snacks may aid Africa mass deworming programs: a preliminary survey. BMC Complement Altern Med. 2018 Dec 7;18(1):327. doi: 10.1186/s12906-018-2379-2.
Results Reference
derived
Learn more about this trial
Design and Clinical Evaluation of a School Meal With Deworming Properties
We'll reach out to this number within 24 hrs